Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cue Biopharma Inc V.CUE


Primary Symbol: CUE

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells. The Company's platform, Immuno-STAT (Selective Targeting and Alteration of T cells) and biologics are designed to harness the curative potential of the body's intrinsic immune system through the selective modulation of disease-specific T cells without the adverse effects of broad systemic immune modulation. Its two oncology drug product candidates, CUE-101 and CUE-102, are exemplary programs from the interleukin 2 (IL-2) based CUE-100 series, and are representative of the HLA-A02 allele, which is prevalent in the United States and western European territories. CUE-101 HLA-A02 is engineered for the treatment of human papillomavirus positive, head and neck squamous cell carcinoma (HNSCC). CUE-102 HLA-A02, targeting Wilms' Tumor 1 protein, an oncofetal antigen known to be over-expressed in more than 20 different cancers.


NDAQ:CUE - Post by User

Comment by nokiawatchon Oct 11, 2011 9:06pm
398 Views
Post# 19139380

RE: 11 Millions lbs of Uranium at $4 mil

RE: 11 Millions lbs of Uranium at $4 mil

  Yes, the Yuty property is so vast and unique. Drilling can take place all months of the year. We will need Uranium to balance the worlds energy needs. When all the political unrest settles, 2012 - 2013 will be interesting years indeed. Will we get the market  price of 2007 -2008 ever again?  Its  possible that this breaks 1.00 in the next 18 months time, depending again on the spot price of U3o8 and investor confidence.  The volatility continues for now, but we have seen some slight improvements . I expect some upticks in the coming months in this sector, but looking at the long term potential, its just damn ridiculous to not buy and hold at this super sale price. Thats just my opinion of course. 

Good Luck

<< Previous
Bullboard Posts
Next >>